Frank Luyten

Frank P. Luyten, MD, PhD and co-founder of Tigenix is amongst other things board certified Rheumatologist, tenured full Professor and Head of the Division of Rheumatology at the University Hospital in Leuven, and director of the Laboratory for Skeletal Development and Joint Disorders at the K.U. Leuven. He obtained his MD, PhD degree and Board Certification in Rheumatology at the University of Ghent, Belgium. Afterwards, he performed a postdoctoral training at the National Institute of Dental Research, National Institutes of Health, Bethesda, MD, USA. He became subsequently group leader of the Developmental Biology Unit at the Bone Research Branch, NIDR, NIH, Bethesda, USA. Two important contributions to his scientific achievements are the discovery of Osteogenin and Cartilage Derived Morphogenetic Proteins. His expertise in regenerative medicine is further supported by contributions in the field of cellular therapeutics, cartilage/joint surface repair and the discovery of adult stem cells in synovial tissue. He serves as advisor and board member of other biotech companies in the field of Regenerative Medicine.

Share |